Insulin derivatives and pharmaceutical preparations containing these derivatives
US5157021A · kind A · utility
42Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 1990 |
| Grant date | Oct 20, 1992 |
| Priority date | — |
| Expiry date | Dec 20, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Insulin derivatives in which from two to four amino acid residues of positions, A4, A17, B13 and B21 comprise an uncharged side chain and pharmaceutical preparations containing these insulin derivatives. The disclosed insulin derivatives and preparations possess protracted insulin activity. The protracted insulin activity is relatively insensitive to tryptic activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.